Changes in background parenchymal enhancement in HER2-positive breast cancer before and after neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Changes in background parenchymal enhancement in HER2-positive breast cancer before and after neoadjuvant chemotherapy

Published:2018-10 Issue:43 Volume:97 Page:e12965
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Dong Jing-Min,Wang Hong-Xia,Zhong Xiao-Fei,Xu Kun,Bian Jia,Feng Yan,Chen Liang,Zhang Lin,Wang Xia,Ma De-Jing,Wang Bin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference30 articles.

1. Progress and new standards of care in the management of HER-2 positive breast cancer;Demonty;Eur J Cancer,2007

2. Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG;Kuroi;Breast Cancer,2015

3. Impact of tumor size on probability of pathologic complete response after neoadjuvant chemotherapy;Baron;Ann Surg Oncol,2016

4. Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA);Schneeweiss;Ann Oncol,2013

5. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy;Londero;Eur Radiol,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Background Parenchymal Enhancement;Radiologic Clinics of North America;2024-07

2. New Frontiers in Breast Cancer Imaging: The Rise of AI;Bioengineering;2024-05-02

3. Predictive value of background parenchymal enhancement on breast magnetic resonance imaging for pathological tumor response to neoadjuvant chemotherapy in breast cancers: a systematic review;Cancer Imaging;2024-03-11

4. Research Progress on Prognostic Indicators of Neoadjuvant Therapy for HER-2 Positive Breast Cancer;Advances in Clinical Medicine;2024

5. Automated Quantification of Background Parenchymal Enhancement in Longitudinal Dynamic Contrast-Enhanced MRI for Predicting Neo-adjuvant Chemotherapy Response in Breast Cancer;2023-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3